NexImmune, Inc. Multiple Myeloma Research Foundation (MMRF) Venture Philanthropy Fund Invests in NexImmune to Advance Novel Immunotherapy Candidate Into Clinical Trials Partnership yields the first investment from newly launched MMRF…
Read More
NexImmune, Inc. Multiple Myeloma Research Foundation (MMRF) Venture Philanthropy Fund Invests in NexImmune to Advance Novel Immunotherapy Candidate Into Clinical Trials Partnership yields the first investment from newly launched MMRF…
Poseida Therapeutics and Rapha Capital Management Rapha Capital Management Participates in Series C Financing for Poseida Therapeutics, Inc. Led by Novartis Pharmaceuticals April 22, 2019
Poseida Therapeutics Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round April 22, 2019
3DBio Therapeutics 3DBio Therapeutics Announces Appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to Board of Directors April 1, 2019